Cargando…

Developing COVID-19 vaccine recommendations during the pandemic: The experience of Serbia's Expert Committee on Immunization

A National Immunization Technical Advisory Group (NITAG) is a multi-disciplinary body of national experts that provide evidence-based recommendations to policy-makers to assist them in making informed immunization policy and programme decisions. During the COVID-19 pandemic, NITAGs faced many challe...

Descripción completa

Detalles Bibliográficos
Autores principales: Markovic-Denic, Ljiljana, Popadic, Dusan, Jovanovic, Tanja, Bonaci-Nikolic, Branka, Samardzic, Janko, Tomic Spiric, Vesna, Rancic, Miljan, Sankar Datta, Siddhartha, Mosina, Liudmila, Jancic, Jasna, Vukomanovic, Goran, Jovanovic, Verica, Vukomanovic, Vladislav, Antic, Darko, Veljkovic, Marko, Saponjic, Vladan, Jacques-Carroll, Lisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713902/
https://www.ncbi.nlm.nih.gov/pubmed/36466511
http://dx.doi.org/10.3389/fpubh.2022.1056670
_version_ 1784842114498035712
author Markovic-Denic, Ljiljana
Popadic, Dusan
Jovanovic, Tanja
Bonaci-Nikolic, Branka
Samardzic, Janko
Tomic Spiric, Vesna
Rancic, Miljan
Sankar Datta, Siddhartha
Mosina, Liudmila
Jancic, Jasna
Vukomanovic, Goran
Jovanovic, Verica
Vukomanovic, Vladislav
Antic, Darko
Veljkovic, Marko
Saponjic, Vladan
Jacques-Carroll, Lisa
author_facet Markovic-Denic, Ljiljana
Popadic, Dusan
Jovanovic, Tanja
Bonaci-Nikolic, Branka
Samardzic, Janko
Tomic Spiric, Vesna
Rancic, Miljan
Sankar Datta, Siddhartha
Mosina, Liudmila
Jancic, Jasna
Vukomanovic, Goran
Jovanovic, Verica
Vukomanovic, Vladislav
Antic, Darko
Veljkovic, Marko
Saponjic, Vladan
Jacques-Carroll, Lisa
author_sort Markovic-Denic, Ljiljana
collection PubMed
description A National Immunization Technical Advisory Group (NITAG) is a multi-disciplinary body of national experts that provide evidence-based recommendations to policy-makers to assist them in making informed immunization policy and programme decisions. During the COVID-19 pandemic, NITAGs faced many challenges in making evidence-based recommendations for COVID-19 vaccines due to the rapidly evolving situation with new vaccine products available in a short time period and limited data on vaccine effectiveness. The authors reviewed the process used by Serbia's NITAG, which is called the Serbian Expert Committee on Immunization, to develop COVID-19 vaccine recommendations during the pandemic. The article examines the challenges and successes faced by the committee. Serbia's expert committee used the best available evidence to develop over forty recommendations on all aspects of COVID-19 vaccination. These expert committee recommendations facilitated the early procurement and successful roll-out of COVID-19 vaccines, guidance for vaccination of individuals at the highest risk, and high COVID-19 vaccination coverage in the country. The availability of five COVID-19 vaccines in Serbia was an advantage for the successful roll-out but posed challenges for the expert committee. Serbia's expert committee plans to use the experience and best practices developed during the pandemic to improve and expand its work moving forward.
format Online
Article
Text
id pubmed-9713902
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97139022022-12-02 Developing COVID-19 vaccine recommendations during the pandemic: The experience of Serbia's Expert Committee on Immunization Markovic-Denic, Ljiljana Popadic, Dusan Jovanovic, Tanja Bonaci-Nikolic, Branka Samardzic, Janko Tomic Spiric, Vesna Rancic, Miljan Sankar Datta, Siddhartha Mosina, Liudmila Jancic, Jasna Vukomanovic, Goran Jovanovic, Verica Vukomanovic, Vladislav Antic, Darko Veljkovic, Marko Saponjic, Vladan Jacques-Carroll, Lisa Front Public Health Public Health A National Immunization Technical Advisory Group (NITAG) is a multi-disciplinary body of national experts that provide evidence-based recommendations to policy-makers to assist them in making informed immunization policy and programme decisions. During the COVID-19 pandemic, NITAGs faced many challenges in making evidence-based recommendations for COVID-19 vaccines due to the rapidly evolving situation with new vaccine products available in a short time period and limited data on vaccine effectiveness. The authors reviewed the process used by Serbia's NITAG, which is called the Serbian Expert Committee on Immunization, to develop COVID-19 vaccine recommendations during the pandemic. The article examines the challenges and successes faced by the committee. Serbia's expert committee used the best available evidence to develop over forty recommendations on all aspects of COVID-19 vaccination. These expert committee recommendations facilitated the early procurement and successful roll-out of COVID-19 vaccines, guidance for vaccination of individuals at the highest risk, and high COVID-19 vaccination coverage in the country. The availability of five COVID-19 vaccines in Serbia was an advantage for the successful roll-out but posed challenges for the expert committee. Serbia's expert committee plans to use the experience and best practices developed during the pandemic to improve and expand its work moving forward. Frontiers Media S.A. 2022-11-17 /pmc/articles/PMC9713902/ /pubmed/36466511 http://dx.doi.org/10.3389/fpubh.2022.1056670 Text en Copyright © 2022 Markovic-Denic, Popadic, Jovanovic, Bonaci-Nikolic, Samardzic, Tomic Spiric, Rancic, Sankar Datta, Mosina, Jancic, Vukomanovic, Jovanovic, Vukomanovic, Antic, Veljkovic, Saponjic and Jacques-Carroll. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Public Health
Markovic-Denic, Ljiljana
Popadic, Dusan
Jovanovic, Tanja
Bonaci-Nikolic, Branka
Samardzic, Janko
Tomic Spiric, Vesna
Rancic, Miljan
Sankar Datta, Siddhartha
Mosina, Liudmila
Jancic, Jasna
Vukomanovic, Goran
Jovanovic, Verica
Vukomanovic, Vladislav
Antic, Darko
Veljkovic, Marko
Saponjic, Vladan
Jacques-Carroll, Lisa
Developing COVID-19 vaccine recommendations during the pandemic: The experience of Serbia's Expert Committee on Immunization
title Developing COVID-19 vaccine recommendations during the pandemic: The experience of Serbia's Expert Committee on Immunization
title_full Developing COVID-19 vaccine recommendations during the pandemic: The experience of Serbia's Expert Committee on Immunization
title_fullStr Developing COVID-19 vaccine recommendations during the pandemic: The experience of Serbia's Expert Committee on Immunization
title_full_unstemmed Developing COVID-19 vaccine recommendations during the pandemic: The experience of Serbia's Expert Committee on Immunization
title_short Developing COVID-19 vaccine recommendations during the pandemic: The experience of Serbia's Expert Committee on Immunization
title_sort developing covid-19 vaccine recommendations during the pandemic: the experience of serbia's expert committee on immunization
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713902/
https://www.ncbi.nlm.nih.gov/pubmed/36466511
http://dx.doi.org/10.3389/fpubh.2022.1056670
work_keys_str_mv AT markovicdenicljiljana developingcovid19vaccinerecommendationsduringthepandemictheexperienceofserbiasexpertcommitteeonimmunization
AT popadicdusan developingcovid19vaccinerecommendationsduringthepandemictheexperienceofserbiasexpertcommitteeonimmunization
AT jovanovictanja developingcovid19vaccinerecommendationsduringthepandemictheexperienceofserbiasexpertcommitteeonimmunization
AT bonacinikolicbranka developingcovid19vaccinerecommendationsduringthepandemictheexperienceofserbiasexpertcommitteeonimmunization
AT samardzicjanko developingcovid19vaccinerecommendationsduringthepandemictheexperienceofserbiasexpertcommitteeonimmunization
AT tomicspiricvesna developingcovid19vaccinerecommendationsduringthepandemictheexperienceofserbiasexpertcommitteeonimmunization
AT rancicmiljan developingcovid19vaccinerecommendationsduringthepandemictheexperienceofserbiasexpertcommitteeonimmunization
AT sankardattasiddhartha developingcovid19vaccinerecommendationsduringthepandemictheexperienceofserbiasexpertcommitteeonimmunization
AT mosinaliudmila developingcovid19vaccinerecommendationsduringthepandemictheexperienceofserbiasexpertcommitteeonimmunization
AT jancicjasna developingcovid19vaccinerecommendationsduringthepandemictheexperienceofserbiasexpertcommitteeonimmunization
AT vukomanovicgoran developingcovid19vaccinerecommendationsduringthepandemictheexperienceofserbiasexpertcommitteeonimmunization
AT jovanovicverica developingcovid19vaccinerecommendationsduringthepandemictheexperienceofserbiasexpertcommitteeonimmunization
AT vukomanovicvladislav developingcovid19vaccinerecommendationsduringthepandemictheexperienceofserbiasexpertcommitteeonimmunization
AT anticdarko developingcovid19vaccinerecommendationsduringthepandemictheexperienceofserbiasexpertcommitteeonimmunization
AT veljkovicmarko developingcovid19vaccinerecommendationsduringthepandemictheexperienceofserbiasexpertcommitteeonimmunization
AT saponjicvladan developingcovid19vaccinerecommendationsduringthepandemictheexperienceofserbiasexpertcommitteeonimmunization
AT jacquescarrolllisa developingcovid19vaccinerecommendationsduringthepandemictheexperienceofserbiasexpertcommitteeonimmunization